Roflumilast

Information about Roflumilast

Roflumilast uses

Roflumilast is used to prevent chronic obstructive pulmonary disease.

How roflumilast works

Roflumilast works by relaxing the muscles in the walls of the airways. This opens the airways and makes breathing easier.

Common side effects of roflumilast

Headache, Weight loss, Dizziness, Insomnia (difficulty in sleeping), Back pain, Nausea, Diarrhea, Decreased appetite, Anxiety, Tremors, Abdominal pain, Hypersensitivity, Vertigo, Palpitations, Stomach inflammation, Vomiting, Gastro-esophageal reflux disease, Indigestion, Rash, Muscle spasm, Muscle weakness, Muscle pain, General discomfort, Weakness, Fatigue, Angioedema (swelling of deeper layers of skin), Breast enlargement in male, Suicidal behaviors, Depression, Nervousness, Panic attacks, Difficulty in swallowing, Respiratory tract infection, Rectal bleeding, Constipation, Red spots or bumps, Increased creatine phosphokinase (CPK) level in blood, Increased gamma-glutamyltransferase, Increased aspartate aminotransferase

Available Medicine for Roflumilast

  • ₹235
    Lupin Ltd
    1 variant(s)
  • ₹137
    Cipla Ltd
    1 variant(s)
  • ₹136
    Intas Pharmaceuticals Ltd
    1 variant(s)
  • ₹150
    MSN Laboratories
    1 variant(s)
  • ₹125
    Glenmark Pharmaceuticals Ltd
    1 variant(s)
  • ₹135
    La Renon Healthcare Pvt Ltd
    1 variant(s)
  • ₹125
    Sun Pharmaceutical Industries Ltd
    1 variant(s)
  • ₹125
    Cadila Pharmaceuticals Ltd
    1 variant(s)
  • ₹125
    Centaur Pharmaceuticals Pvt Ltd
    1 variant(s)
  • ₹150
    Alembic Pharmaceuticals Ltd
    1 variant(s)

Expert advice for Roflumilast

  • Roflumilast is not effective and should not be used for sudden attacks of breathlessness (acute bronchospasm).
  • You should not take roflumilast if you have a history of depression and suicidal behavior/thoughts.
  • You should have your weight monitored regularly. Stop taking roflumilast and seek advice if you experience unexplained and significant weight loss while on treatment.
  • Roflumilast controls COPD but does not cure it. It is important to continue taking roflumilast even if you feel well unless advised otherwise.
  • Roflumilast may cause dizziness, which can aggravate with alcohol intake. Do not drive or operate any machinery until you feel fine.
  • You should not take roflumilast if you have any serious disease affecting your immune system (HIV, multiple sclerosis, lupus erythematosus, progressive multifocal leukoencephalopathy) or if you are receiving treatments that act on your immune system for certain cancers or serious infections.
  • Tell your doctor if you are or planning to become pregnant or are breastfeeding.

Frequently asked questions for Roflumilast

Roflumilast

Q. Is Roflumilast a methylxanthine?
No. Roflumilast is not a methylxanthine and works via a different mechanism of action
Q. Is Roflumilast available in India?
Yes. Roflumilast is available in India in the form of 500 mcg tablet
Q. Is Roflumilast a steroid/ narcotic?
No. Roflumilast belongs to a class of drugs called phosphodiesterase inhibitors. It does not have a chemical structure or effects similar to steroids. It does not induce sleep and is not a narcotic drug
Show More
Q. What is Roflumilast used for?
Roflumilast is used as a maintenance treatment for severe chronic obstructive pulmonary disease (COPD; a group of lung disorders in which the flow of air to the lungs is blocked) in patients with frequent worsening of COPD symptoms (COPD exacerbations) and with long-term inflammation of airways (chronic bronchitis)
Q. How does Roflumilast work?
Roflumilast is used to prevent worsening of symptoms in patients with severe chronic obstructive pulmonary disease (COPD; a group of lung disorders in which the flow of air to the lungs is blocked) and long-term inflammation of airways (chronic bronchitis)
Q. How long does Roflumilast take to work?
Roflumilast may need to be taken for several weeks to achieve its effects and may vary upon individual response. Please follow advice of your doctor regarding dose and duration.

Content on this page was last updated on 07 June, 2022, by Dr. Varun Gupta (MD Pharmacology)